DFX Intelligence
Private Credit Intelligence
The capital structure graph behind private markets. Who lent, to whom, under which sponsor, through which facility, how large the piece was, when it matures and what changed, with a filing behind every number. A BDC piece is that BDC's piece, a sum of pieces is a lower bound, and a sponsor is named with the evidence that names it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
BDC portfolio
H••••••• C••••••• I•••
BDCHTGC, HCXYCIK 1280784file 814-00702SAN MATEO, CAinternally managed
Fair value
$5.1B
as of Jun 30, 2026
Principal held
$4.8B
debt pieces, the filer's figure
Cost
$5.1B
99c on cost
Unfunded
$408M
commitments not yet drawn
Positions
459
218 borrowers
First lien
88%
95% debt by fair value
Quarters on the tape
15
since Dec 31, 2022
Facilities held
360
44 sponsors financed
Portfolio through time
Fair value by quarter end$5.1B as of Jun 30, 2026
Dec 31, 2022$15B then
| Quarter | Fair value | Borrowers | On cost | PIK pos. | Avg spread |
|---|---|---|---|---|---|
| Jun 30, 2026 | $5.1B | 218 | 99c | 55 | 351 bp |
| Mar 31, 2026 | $5.6B | 244 | 99c | 61 | 360 bp |
| Dec 31, 2025 | $9.7B | 284 | 100c | 112 | 353 bp |
| Sep 30, 2025 | $5.2B | 222 | 100c | 60 | 376 bp |
| Jun 30, 2025 | $26B | 213 | 100c | 59 | 381 bp |
| Mar 31, 2025 | $24B | 210 | 99c | 55 | 385 bp |
| Dec 31, 2024 | $37B | 264 | 100c | 95 | 440 bp |
| Sep 30, 2024 | $18B | 214 | 99c | 54 | 473 bp |
| Jun 30, 2024 | $18B | 217 | 100c | 52 | 488 bp |
| Mar 31, 2024 | $18B | 222 | 100c | 50 | 492 bp |
| Dec 31, 2023 | $32B | 227 | 100c | 119 | 511 bp |
| Sep 30, 2023 | $17B | 223 | 98c | 46 | 519 bp |
| Jun 30, 2023 | $16B | 220 | 100c | 41 | 533 bp |
| Mar 31, 2023 | $19B | 224 | 99c | 42 | 549 bp |
| Dec 31, 2022 | $15B | 230 | 99c | 39 | 569 bp |
Each quarter end is the schedule as filed for that instant; a restated year end is taken from the latest filing that carries it.
Sponsors financed
- 7 borrowers $135M
- V••••• G••••• I•••••••• L• carried4 borrowers $75.2M
- S••••••••• C•••••• P••••••• carried3 borrowers $16.7M
- P••••••• P•••••••• L••• carried2 borrowers $221M
- A•••••• C•••••• M••••••••• L• carried2 borrowers $119M
- A•••••••• carried2 borrowers $73.9M
- 2 borrowers $71.2M
- R•• C•••••• P••••••• carried2 borrowers $45.0M
- F•••••••• P••••••• carried2 borrowers $44.9M
- H••••••• V••••••• M••••••••• L•• carried2 borrowers $37.3M
- G•••• C•••••• M••••••••• L•• carried1 borrower $190M
- M•• B•••••••• carried1 borrower $142M
- 1 borrower $133M
- W••••••••• H•••••• P••••••• L• carried1 borrower $114M
- S• C•••••• P••••••• carried1 borrower $67.1M
Counted at BDC level here; the adviser page counts across every BDC it manages. A sponsor named by Form D signer consensus is an inference.
What changed
- Repeat sponsor and lender pairJun 30, 2026
- New sponsor and lender pairJun 30, 2026
- Repeat sponsor and lender pairJun 30, 2026
- New sponsor and lender pairJun 30, 2026
- Repeat sponsor and lender pairJun 30, 2026
- Repeat sponsor and lender pairJun 30, 2026
- Repeat sponsor and lender pairJun 30, 2026
- Repeat sponsor and lender pairJun 30, 2026
- Repeat sponsor and lender pairJun 30, 2026
- New sponsor and lender pairJun 30, 2026
- New sponsor and lender pairJun 30, 2026
- New sponsor and lender pairJun 30, 2026
- New sponsor and lender pairJun 30, 2026
- New sponsor and lender pairJun 30, 2026
- New sponsor and lender pairJun 30, 2026
- New sponsor and lender pairJun 30, 2026
- Repeat sponsor and lender pairJun 30, 2026
- New borrower on a BDC scheduleJun 30, 2026
- New sponsor and lender pairJun 30, 2026
- New sponsor and lender pairJun 30, 2026
Largest facilities held, with co-lenders
- S••••• S••••••• first lien term loan1 BDC hold it · matures Jan 1, 2031$504M 99c
- D•••••• T••••••••• first lien term loan1 BDC hold it · matures Jun 1, 2030$237M 102c
- M••••••• H•••••• L•• first lien term loan1 BDC hold it · matures Feb 1, 2029 · P••••••• P•••••••• L•••$185M 99c
- D••• T••••••••• I•• first lien term loan1 BDC hold it · matures Jul 1, 2030 · M•• B••••••••$142M 102c
- P•••••• P••••••••• I•• first lien term loan1 BDC hold it · matures Feb 1, 2029 · N•••••••• C•••••• M••••••••• L•••••$133M 101c
- C••••••• L•• first lien term loan1 BDC hold it · matures May 1, 2030$130M 100c
- T•••••• S•••••••• L•• first lien term loan1 BDC hold it · matures Apr 1, 2029$117M 99c
- H•••• T••••••••• I•• first lien term loan1 BDC hold it · matures Sep 1, 2030$80.8M 97c
- B••• S•••• P••••••••• I•• first lien term loan1 BDC hold it · matures Nov 1, 2026$77.3M 99c
- A•••• B••••••••• I•• first lien term loan1 BDC hold it · matures Sep 1, 2030$76.5M 105c
- X• P••••••••• I•• first lien term loan1 BDC hold it · matures Jul 1, 2027$75.0M 100c
- M••• S••••• R••••• I•• first lien term loan1 BDC hold it · matures Jul 1, 2027$73.5M 100c
Schedule of investments at Jun 30, 2026
459 positions
| Borrower | Instrument | Principal | Fair value | Rate | Maturity |
|---|---|---|---|---|---|
| A••••••••• I••. Consumer & Business Services | warrants equity | n/a | $79,000 31c | ||
| V••• H•••••• I••. H••••••••• Services, Other | preferred equity equity | n/a | $77,000 64c | ||
| P••• T•••••• I••. Consumer & Business Services | warrants equity | n/a | $74,000 47c | ||
| L••••••• A••, Equity, 8/25/2023 Application S••••••• | preferred equity equity | n/a | $70,000 28c | ||
| S•••••• I••., Equity, 8/11/2015 Drug D•••overy & Development | equity equity | n/a | $68,000 33c | ||
| B•••• C••••••••• Application S••••••• | warrants equity | n/a | $67,000 31c | ||
| S••••••••• H•••••••• I••. Medical Devices & Equipment | warrants equity | n/a | $65,000 24c | ||
| P•••••• P••••••••• I••. Drug D•••overy & Development | warrants equity | n/a | $63,000 7c | ||
| S••••• S•••••••, Morphisec Information S••••••• 2014 Ltd. | warrants equity | n/a | $63,000 61c | ||
| S••••• S•••••••, Neo4j, Inc. | warrants equity | n/a | $62,000 148c | ||
| A••••••• S••••••••• C••••••••• S•••••••••s | preferred equity equity | n/a | $59,000 64c | ||
| U••••• I••. Application S••••••• | warrants equity | n/a | $56,000 21c | ||
| A•••••••• I••. Consumer & Business Services | warrants equity | n/a | $53,000 42c | ||
| F•••• L•••• I••. Media/Content/Info | preferred equity equity | n/a | $50,000 75c | ||
| F••••• H•••••• A• (publ) Application S••••••• | warrants equity | n/a | $44,000 86c | ||
| P•••••••• L•• Consumer & Business Services | warrants equity | n/a | $41,000 68c | ||
| Z•••••••• I••. Application S••••••• | warrants equity | n/a | $38,000 27c | ||
| T•••••• S•••••••• L••. Application S••••••• | warrants equity | n/a | $38,000 28c | ||
| T••••• W•••••••• I••.. Communications & Networking | warrants equity | n/a | $37,000 86c | ||
| F••••••••• I••., Equity, 4/30/2010 Consumer & Business Products | equity equity | n/a | $35,000 27c | ||
| K••••••• I••. Application S••••••• | preferred equity equity | n/a | $35,000 17c | ||
| S••••• S•••••••, Scylla DB Ltd. | warrants equity | n/a | $33,000 63c | ||
| S••••• S•••••••, ControlUp T••••••••• Ltd. | warrants equity | n/a | $32,000 97c | ||
| C••••••• I••. Application S••••••• | warrants equity | n/a | $32,000 123c | ||
| e••••• T••••••••• I••. (p.k.a. enGene, Inc.) Drug D•••overy & Development | warrants equity | n/a | $29,000 13c | ||
| C••••• L•• Consumer & Business Services | preferred equity equity | n/a | $27,000 135c | ||
| D•••••• I••. Application S••••••• | preferred equity equity | n/a | $24,000 92c | ||
| D••••••••• I••. Application S••••••• | warrants equity | n/a | $21,000 4c | ||
| A•••••, PBC Sustainable and Renewable T••••••••• | warrants equity | n/a | $20,000 38c | ||
| K••• O•••••••• I••. Drug D•••overy & Development | warrants equity | n/a | $19,000 22c | ||
| A••••••• S••••••••• C•••••••••, Equity, 7/1/2011 S•••••••••s | preferred equity equity | n/a | $17,000 11c | ||
| R••••••• B••••••••• I••. Drug D•••overy & Development | preferred equity equity | n/a | $16,000 80c | ||
| G•••• C••••••••• I••., Equity, 4/30/2021 Consumer & Business Products | equity equity | n/a | $15,000 3c | ||
| C••••••••• I••. Consumer & Business Services | warrants equity | n/a | $13,000 62c | ||
| D•••••••• I••., Equity, 3/21/2014 Application S••••••• | preferred equity equity | n/a | $12,000 12c | ||
| L••••••• A•• Application S••••••• | warrants equity | n/a | $11,000 28c | ||
| T•••••••• I••., Equity, 12/10/2018 Drug Delivery | equity equity | n/a | $9,000 1c | ||
| X• P••••••••• I••. Drug D•••overy & Development | warrants equity | n/a | $8,000 2c | ||
| W••••••••• G•••• L•••••• Consumer & Business Services | preferred equity equity | n/a | $6,000 5c | ||
| Total W••••••••• G•••• L•••••• Consumer & Business Services | unstated lien unstated | n/a | $6,000 4c | ||
| Total S••••••• I••. Consumer & Business Services | unstated lien unstated | n/a | $4,000 3c | ||
| S••••••• I••. Consumer & Business Services | warrants equity | n/a | $4,000 7c | ||
| S•••••• L••. Application S••••••• | warrants equity | n/a | $4,000 2c | ||
| H•••• T••••••••• I••. Drug D•••overy & Development | warrants equity | n/a | $4,000 2c | ||
| H••••• I••. Consumer & Business Services | warrants equity | n/a | $3,000 15c | ||
| L•••••• I••. Consumer & Business Services | preferred equity equity | n/a | $3,000 8c | ||
| R••••• P••••••••• L••., Equity, 8/22/2007 Drug D•••overy & Development | equity equity | n/a | $3,000 0c | ||
| L•••••• H••••••• I••. Consumer & Business Services | warrants equity | n/a | $3,000 3c | ||
| P•• B••••••••• C•••••••••, Equity, 4/6/2015 Drug Delivery | equity equity | n/a | $2,000 1c | ||
| D••• B••••••••• I••., Equity, 1/8/2015 Drug D•••overy & Development | equity equity | n/a | $2,000 0c | ||
| V•••• I••. Consumer & Business Services | warrants equity | n/a | $2,000 2c | ||
| A••• B••••••••• I••., Equity, 3/28/2014 Drug Delivery | equity equity | n/a | $2,000 0c | ||
| A•••• T••••••••• I••., Equity, 8/19/2014 Drug D•••overy & Development | equity equity | n/a | $1,000 0c | ||
| C•••••• T••••••••• I••. Drug D•••overy & Development | warrants equity | n/a | $1,000 3c | ||
| S••••• S•••••••, Coronet Cyber S••••••• Ltd. | warrants equity | n/a | $1,000 0c | ||
| C••••••••• I••., Equity, 10/26/2012 Application S••••••• | preferred equity equity | n/a | $0 0c | ||
| A•••• C•••• Application S••••••• | warrants equity | n/a | $0 | ||
| Total S••••••••• I••. Consumer & Business Services | unstated lien unstated | n/a | $0 0c | ||
| G••••• G••••• L•• Consumer & Business Products | warrants equity | n/a | $0 0c | ||
| A••••• N•••••••• I••. Communications & Networking | warrants equity | n/a | $0 0c | ||
| S••••••• E•••••• I••., Equity, 12/10/2020 Sustainable and Renewable T••••••••• | equity equity | n/a | $0 0c | ||
| S••••• S•••••••, Lightbend, Inc. | preferred equity equity | n/a | $0 0c | ||
| S••••••••• I••. Consumer & Business Services | preferred equity equity | n/a | $0 0c | ||
| S••••••••• I••. Consumer & Business Services | warrants equity | n/a | $0 0c | ||
| R•••• L•••• I••. Consumer & Business Services | warrants equity | n/a | $0 0c | ||
| S••••• S•••••••, C••••ian, Inc. | warrants equity | n/a | $0 0c | ||
| P•••• Consumer & Business Services | warrants equity | n/a | $0 0c | ||
| J••••••••• U••• I••., Equity, 2/11/2025 Consumer & Business Services | preferred equity equity | n/a | $0 0c | ||
| M••••••••• T•••••••••, MacroFab, Inc. | warrants equity | n/a | $0 0c | ||
| M••••••••• I••., Equity, 6/1/2015 Sustainable and Renewable T••••••••• | equity equity | n/a | $0 0c | ||
| S•••• I••. Application S••••••• | warrants equity | n/a | $0 0c | ||
| S••••••• I••. Consumer & Business Services | preferred equity equity | n/a | $0 0c | ||
| N•••••• Q•••• I••. Information Services | preferred equity equity | n/a | $0 0c | ||
| C••••••• A••••••••• L••, Equity, 10/15/2021 Medical Devices & Equipment | equity equity | n/a | $0 | ||
| A•••• C•••• Application S••••••• | term loan first lien | $1.7M | $0 0c | S+573 bp PIK 5.73% | Jun 1, 2028 |
| S••••• S•••••••, Lightbend, Inc., Equity, 12/4/2020 | equity equity | n/a | $0 0c | ||
| S•••••••• I••. Drug D•••overy & Development | warrants equity | n/a | $0 0c | ||
| B••• P••••• I•••••••••, Equity, 12/8/2015 Drug Delivery | preferred equity equity | n/a | $0 0c | ||
| R••••••••• P••••• I••., Equity, 7/31/2020 Consumer & Business Services | equity equity | n/a | $0 0c | ||
| T•••••• C•••••••••, Equity, 6/6/2016 Consumer & Business Services | preferred equity equity | n/a | $0 | ||
| F•••• I••••••• I••. Application S••••••• | preferred equity equity | n/a | $0 0c | ||
| T••• B••• I••. Medical Devices & Equipment | warrants equity | n/a | $0 0c | ||
| S••••• S•••••••, C••••Bolt S•••••••, Inc. | warrants equity | n/a | $0 0c | ||
| T•••••• C•••••••••, Equity, 5/23/2018 Consumer & Business Services | equity equity | n/a | $0 0c | ||
| W••••••••• G•••• L•••••• Consumer & Business Services | preferred equity equity | n/a | $0 0c | ||
| R••••• H•••••••• I••., Equity, 4/6/2021 Drug D•••overy & Development | equity equity | n/a | $0 0c | ||
| R•••• L•••• I••., Equity, 1/24/2022 Consumer & Business Services | equity equity | n/a | $0 0c | ||
| V•••••••• I••. Application S••••••• | warrants equity | n/a | $0 0c | ||
| S•••• D•••• I••. Application S••••••• | warrants equity | n/a | $0 0c | ||
| A•••• C•••• Application S••••••• | term loan first lien | $5.6M | $0 0c | S+999 bp PIK 9.99% | Jun 1, 2028 |
| V••••• H•••••• I••., Equity, 7/8/2021 Application S••••••• | equity equity | n/a | $0 0c | ||
| C••••••••• H••••• H•••••••• L•• | unstated lien unstated | n/a | n/a | ||
| D••• M•••••••• I••. | unstated lien unstated | n/a | n/a | ||
| B•••••• L•••••• | unstated lien unstated | n/a | n/a | ||
| M••••••• H•••••• L•• | unstated lien unstated | n/a | n/a | ||
| E•••••• H•••••• I••. | unstated lien unstated | n/a | n/a | ||
| S••••••••• H••••••••• S•••••••• | unstated lien unstated | n/a | n/a | ||
| D••••••••• | term loan first lien | n/a | n/a | ||
| B••••• H•••••• I••. | unstated lien unstated | n/a | n/a | ||
| A••••••• S••••••• L••. | unstated lien unstated | n/a | n/a |
Registration
- Fiscal year end
- 1231reported
- Incorporated
- MDreported
- On the SEC BDC report
- 2012 to 2026reported
- Filings listed
- 19reported10-Q and 10-K since 2022
- Former names
- HERCULES TECHNOLOGY GROWTH CAPITAL INCreported
- Latest schedule
- 0001280784-26-000042reported